Faculty Opinions recommendation of Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy.

2012 ◽  
Author(s):  
Hendrik van Poppel ◽  
Yuri Tolkach
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gonadotropin Releasing Hormone ◽  
Prostate Cancer Progression ◽  
Agonist Therapy ◽  
Releasing Hormone ◽  
Gonadotropin Releasing Hormone Agonist ◽  
Androgen Independent

Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer

2006 ◽  
Vol 175 (1) ◽  
pp. 136???139 ◽  
Author(s):  
Matthew R. Smith ◽  
Simone Peart Boyce ◽  
Erick Moyneur ◽  
Mei Sheng Duh ◽  
Monika K. Raut ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Gonadotropin Releasing Hormone ◽  
Agonist Therapy ◽  
Releasing Hormone ◽  
Gonadotropin Releasing Hormone Agonist ◽  
Clinical Fractures

Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer

2006 ◽  
Vol 175 (1) ◽  
pp. 136-139 ◽  
Author(s):  
Matthew R. Smith ◽  
Simone Peart Boyce ◽  
Erick Moyneur ◽  
Mei Sheng Duh ◽  
Monika K. Raut ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Gonadotropin Releasing Hormone ◽  
Agonist Therapy ◽  
Releasing Hormone ◽  
Gonadotropin Releasing Hormone Agonist ◽  
Clinical Fractures

scholarly journals Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer

Cancer ◽  
2008 ◽  
Vol 112 (10) ◽  
pp. 2188-2194 ◽  
Author(s):  
Matthew R. Smith ◽  
Hang Lee ◽  
Francis McGovern ◽  
Mary Anne Fallon ◽  
Melissa Goode ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Gonadotropin Releasing Hormone ◽  
Metabolic Changes ◽  
Agonist Therapy ◽  
Releasing Hormone ◽  
Gonadotropin Releasing Hormone Agonist

463: Telomerase Inhibition Prevents Androgen Independent Osseous Prostate Cancer Progression

2005 ◽  
Vol 173 (4S) ◽  
pp. 126-127
Author(s):  
Yingming Li ◽  
Melissa Thompson ◽  
Zhu Chen ◽  
Bahaa S. Malaeb ◽  
David Corey ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Progression ◽  
Prostate Cancer Progression ◽  
Telomerase Inhibition ◽  
Androgen Independent

scholarly journals A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

2006 ◽  
Vol 12 (4) ◽  
pp. 1260-1269 ◽  
Author(s):  
Philip M Arlen ◽  
James L Gulley ◽  
Catherine Parker ◽  
Lisa Skarupa ◽  
Mary Pazdur ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Randomized Phase Ii ◽  
Androgen Independent
Sign in / Sign up

Export Citation Format

Share Document